Clinical Trials Browser

Phase 1 × Interventional × Lethal Congenital Contracture Syndrome 2 × Clear all

Diabetes Mellitus, Insulin-Dependent, 12, Lethal Congenital Contracture Syndrome 2, Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Multiple Endocrine Neoplasia Type 2a

NCT00734305 2016-09-01

Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Phase 1 Completed

44 enrolled 12 charts

Lethal Congenital Contracture Syndrome 2, Neoplasms

NCT00730470 2010-07-29

Phase I Study of U3P1287/01, Including Patients With Advanced Solid Tumors

Phase 1 Completed

60 enrolled

Lethal Congenital Contracture Syndrome 2, Fibromatosis, Gingival, 2

Clinical Trials

LuCa-MERIT-1

Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Phase I Study of U3P1287/01, Including Patients With Advanced Solid Tumors